1 treatment center
No centers match
Try a different search term
1 SAMHSA-listed treatment center in Lexington, Virginia. Free, confidential help available 24/7 — most callers reach a licensed counselor in under 60 seconds.
Try a different search term
Free, confidential assistance matching you with the right program in Lexington.
Lexington, Virginia has 1 SAMHSA-verified addiction treatment center offering 1 outpatient. Each facility listed here is verified through the Substance Abuse and Mental Health Services Administration (SAMHSA) and provides evidence-based treatment approaches.
Outpatient programs allow Lexington residents to receive treatment while maintaining their daily responsibilities. Sessions are typically scheduled 3-5 days per week, making it possible to continue working or attending school.
Treatment centers in Lexington accept most major insurance plans including Medicaid, Medicare, Blue Cross Blue Shield, Aetna, Cigna, and UnitedHealthcare. Many facilities also offer sliding scale fees and payment plans. Call (319) 271-2077 to verify your coverage before admission.
Veterans in Lexington have additional federal resources: the VA Mental Health Services (including addiction treatment), Veterans Crisis Line (988, press 1), VA Vet Centers (free, confidential counseling for combat-related issues including substance use), and Tricare-covered civilian treatment when VA care is unavailable. Service-connected substance-use disorders qualify for VA disability benefits. The VA's National Center for PTSD provides specialized trauma-focused care including for veterans whose substance use intersects with combat trauma.
The first 90 days post-discharge are the highest-relapse-risk window for Lexington patients leaving residential treatment — multiple studies place 60-70% of relapses within this window. Structured continuity matters: same-team outpatient continuity, scheduled check-ins, structured-day expectations, and mutual-support engagement reduce 90-day relapse risk substantially compared to discharge-and-good-luck approaches. Programs that build this continuity into their model report measurably better outcomes than those treating discharge as the program endpoint.
Anxiety disorders complicate addiction recovery for many Lexington patients, particularly in early recovery when anxiety symptoms often intensify without the substance previously used to suppress them. Treatment approaches include cognitive-behavioral therapy specifically for anxiety, judicious psychiatric medication management (avoiding benzodiazepines for most patients in addiction recovery given the dependence risk), structured exposure work, mindfulness-based interventions, and lifestyle interventions (sleep, exercise, caffeine moderation) that compound the formal treatment effects.
Outpatient counseling in Lexington addresses the lower-intensity end of the continuum — patients in early recovery who've completed higher-intensity programs and need ongoing support, patients with mild substance-use disorders who don't require intensive care, and patients in long-term recovery accessing maintenance therapy. Sessions are typically weekly or bi-weekly, individual and/or group, with content shaped by patient need: relapse-prevention skills, processing of underlying issues, family-system work, or co-occurring mental-health treatment.
Patients arriving at Lexington residential facilities should expect a medical evaluation within hours of admission: vital signs, withdrawal-symptom assessment using validated scales (CIWA for alcohol, COWS for opioids), medication reconciliation with the patient's prescribing providers, and physical examination by nursing or physician staff. Medical stabilization takes priority over therapeutic programming during this early phase — patients in active withdrawal aren't expected to engage in group therapy until stabilization is achieved.
The addiction-treatment landscape in Lexington, Virginia, reflects the broader epidemiology of substance use in the region: alcohol use disorder remains the most prevalent diagnosis at treatment intake nationally, opioid use disorder presents the highest overdose mortality, stimulant use disorder is increasingly common (cocaine and methamphetamine), and polysubstance use is the rule rather than the exception. Lexington providers structure programs to address this diversity — most treat the full range of substance-use disorders within an integrated clinical framework rather than maintaining substance-specific tracks.
Federal parity protections extend beyond just coverage existence to specific plan design elements: prior authorization burden, treatment day limits, financial requirements, and non-quantitative treatment limits must all be comparable between substance-use and medical/surgical benefits. Lexington patients encountering insurer practices that appear to discriminate against addiction-treatment access can file complaints with the Virginia Department of Insurance, the U.S. Department of Labor (for ERISA plans), or the federal Center for Consumer Information and Insurance Oversight.